Current recommendations suggest Pap tests be used as primary screening tools for cervical cancer, but some experts would like to see newer DNA testing used more often.
People are having all kinds of sex, regardless of how they identify their orientation; we need a health-care system that is prepared to address everyone’s questions, issues, and concerns about sex, sexuality, and sexual and reproductive health.
In a recent editorial, Paglia argues for moving toward a sex ed model in which young people learn reproductive biology in one class, study sexually transmitted diseases in another, and get a healthy dose of fear, shame, and gender stereotypes in yet another. But sexuality educators disagree.
Having spent much of my career reviewing abstinence-only-until-marriage curricula and material, I can promise that just adding a lesson about contraception cannot turn a fear- and shame-based program into anything better.
Despite overwhelming scientific evidence showing that vaccines are safe and effective, many parents have become skeptical. Efforts to encourage these parents to change their minds have most often focused on correcting misinformation. A new study, however, suggests that this approach may backfire.
Despite a mounting body of evidence to the contrary, there continues to be a fear among adults that vaccinating young people against an STD is akin to giving them a license to have sex. Yet another study promises this isn’t going to happen.
This week, Chicago launches a new initiative to up the number of teens who get vaccinated for HPV, a Spanish study makes headlines about how rich people supposedly have better sex, and a New York Times op-ed urges safe sex for seniors.
The Centers for Disease Control and Prevention has released sexually transmitted disease surveillance data for 2012, and the news is not good: Cases of chlamydia, gonorrhea, and syphilis all continued to rise.
Recent political developments suggest some growing political awareness of sex workers as human beings.
It was reported recently that French drug manufacturer HRA Pharma had found that the emergency contraceptive Norlevo, which has a similar chemical makeup to Plan B One-Step, is ineffective for women over 176 pounds. Here’s why I was not surprised.